MethylphenidatePriapism following off label use: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2017年 / 1636卷 / 1期

关键词：

D O I：

10.1007/s40278-017-25774-6

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：214 / 214

相关论文

共 50 条

[21] FluoxetineAkathisia following off label use: case report
Reactions Weekly, 2020, 1811 (1) : 130 - 130
[22] OsimertinibPneumonitis following off label use: case report
Reactions Weekly, 2021, 1867 (1) : 340 - 340
[23] AntineoplasticsMyelosuppression following off label use: case report
Reactions Weekly, 2021, 1844 (1) : 46 - 46
[24] AripiprazoleHypothermia following off label use: case report
Reactions Weekly, 2022, 1930 (1) : 91 - 91
[25] RituximabHypotension following off label use: case report
Reactions Weekly, 2018, 1703 (1) : 236 - 236
[26] BevacizumabEndophthalmitis following an off label use: case report
Reactions Weekly, 2017, 1680 (1) : 69 - 69
[27] NivolumabFever following off-label use: case report
Reactions Weekly, 2016, 1601 (1) : 186 - 186
[28] TheophyllineMild headache following an off label use: case report
Reactions Weekly, 2018, 1730 (1) : 281 - 281
[29] RituximabPancytopenia following off-label use: case report
Reactions Weekly, 2020, 1807 (1) : 176 - 176
[30] TocilizumabAnaphylaxis following off-label use: case report
Reactions Weekly, 2021, 1865 (1) : 397 - 397

← 1 2 3 4 5 →